CD19 and plasma cell myeloma: Researchers not only detected RANK on CD19+ B lymphocytes (Atkins et al., 2006) but also observed that peripheral CD19+ B lymphocytes isolated from patients with multiple myeloma exhibit phenotypic and functional properties of osteoclasts upon stimulation with RANKL (Calvani et al., 2004).